Effect of ezetimibe/statin combination therapy in patients with type 2 diabetes and dyslipidemia on remnant and inflammatio

Phase 4

• Conditions: type 2 diabetes with hypercholesterolemia

• Registration Number: JPRN-UMIN000002318
• Lead Sponsor: Kobe University Graduate School of Medicine, Division of Diabetes, Metabolism and Endocrinology

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-08-11
• Study Completion: 2011-03-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Not provided

Exclusion Criteria

1)During pregnancy or lactation 2)Patients who had allergy to ezetimibe 3)Serious liver or renal diseases 4)Acute or chronic inflammatory diseases 5)Other conditions precluding participation as judged by the investigator

Study & Design

• Study Type: Interventional
• Study Design: Not specified